XML 50 R39.htm IDEA: XBRL DOCUMENT v3.22.1
SHARE-BASED COMPENSATION (Tables)
6 Months Ended
May 01, 2022
SHARE-BASED COMPENSATION [Abstract]  
Share-based Compensation Expenses The table below presents information on our share-based compensation expenses for the three and six-month periods ended May 1, 2022, and May 2, 2021.


    Three Months Ended     Six Months Ended  
   
May 1,
2022
   
May 2,
2021
   
May 1,
2022
   
May 2,
2021
 
                         
Expense reported in:
                       
     Cost of goods sold
 
$
182
   
$
97
    $ 324     $ 208  
     Selling, general and administrative
   
1,243
     
1,207
      2,424       2,304  
     Research and development
   
159
     
118
      293       211  
                                 
Total expense incurred
 
$
1,584
   
$
1,422
    $ 3,041     $ 2,723  
                                 
                                 
Expense by award type:
                               
     Restricted stock awards
 
$
1,316
   
$
1,313
    $ 2,683     $ 2,484  
     Stock options
   
221
     
54
      259       138  
     ESPP
   
47
     
55
      99       101  
                                 
Total expense incurred
 
$
1,584
   
$
1,422
    $ 3,041     $ 2,723  
                                 
                                 
Income tax benefits of share-based compensation
 
$
104
   
$
62
    $ 188     $ 108  
Share-based compensation cost capitalized
 
$
-
   
$
-
    $ -     $ -  

Restricted Stock Awards Activity The table below presents information on our restricted stock awards for the three and six-months ended May 1, 2022, and May 2, 2021.


   
Three Months Ended
    Six Months Ended  
   
May 1,
2022
   
May 2,
2021
   
May 1,
2022
   
May 2,
2021
 
Number of shares granted in period
   
-
     
15,000
      535,400       556,200  
Weighted-average grant-date fair value of awards (in dollars per share)
 
$
-
   
$
12.65
    $ 19.28     $ 11.17  
Compensation cost not yet recognized
 
$
10,779
   
$
9,762
    $ 10,779     $ 9,762  
Weighted-average amortization period for cost not yet recognized (in years)
   
2.8
     
2.9
      2.8       2.9  
Shares outstanding at balance sheet date
   
891,429
     
1,022,327
      891,429       1,022,327  
Stock Options Activity The table below presents information on our stock options for the three and six-months ended May 1, 2022, and May 2, 2021.


   
Three Months Ended
    Six Months Ended
 
   
May 1,
2022
   
May 2,
2021
   
May 1,
2022
   
May 2,
2021
 
Number of options granted in period
   
-
     
-
      -       -  
Cash received from option exercised
 
$
438
   
$
309
    $ 4,149     $ 967  
Compensation cost not yet recognized
 
$
52
   
$
232
    $ 52     $ 232  
Weighted-average amortization period for cost not yet recognized (in years)
   
0.7
     
1.4
      0.7       1.4  
Information on Outstanding and Exercisable Option


Information on outstanding and exercisable option awards as of May 1, 2022, is presented below.

Options
 
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Life (in years)
 
Aggregate
Intrinsic
Value
 
                       
Outstanding at May 1, 2022
 
718,213
 
$
9.90
 
3.5
 
$
3,657
 
Exercisable at May 1, 2022
 
693,987
 
$
9.90
 
3.4
 
$
3,531